P2X7 deficiency attenuates hypertension and renal injury in deoxycorticosterone acetate-salt hypertension

American Journal of Physiology - Renal Physiology

Volumn 303, Issue 8, 2012, Pages

  Ji, Xu ^a   Naito, Yukiko ^a   Weng, Huachun ^a   Endo, Kosuke ^a   Ma, Xiao ^a   Iwai, Naoharu ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Hypertension; Immune cell; Inflammation; Renal injury

Indexed keywords

ALBUMIN; CYCLOOXYGENASE 2; DEOXYCORTICOSTERONE; INTERLEUKIN 1BETA; MESSENGER RNA; PURINERGIC P2X7 RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; B LYMPHOCYTE; CELL INFILTRATION; CONTROLLED STUDY; CREATININE CLEARANCE; HEART RATE; HYPERTENSION; IMMUNOHISTOCHEMISTRY; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY MASS; LEUKOCYTE; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MALE; MOUSE; NEPHRITIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; SYSTOLIC BLOOD PRESSURE; T LYMPHOCYTE; URINARY EXCRETION; ALBUMINURIA; ANIMAL; BLOOD PRESSURE; DRUG EFFECT; GENETICS; KIDNEY; KIDNEY DISEASE; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; SALT INTAKE;

ALBUMINURIA; ANIMALS; BLOOD PRESSURE; DESOXYCORTICOSTERONE; HEART RATE; HYPERTENSION; INTERLEUKIN-1BETA; KIDNEY; KIDNEY DISEASES; MALE; MICE; MICE, KNOCKOUT; RECEPTORS, PURINERGIC P2X7; SODIUM CHLORIDE, DIETARY;

EID: 84867697353     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00051.2012     Document Type: Article

References (33)

1. Arulkumaran N, Unwin RJ, Tam FW. A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases. Expert Opin Investig Drugs 20: 897-915, 2011.
2. Barri YM. Hypertension and kidney disease: a deadly connection. Curr Hypertens Rep 10: 39-45, 2008.
3. Basso AM, Bratcher NA, Harris RR, Jarvis MF, Decker MW, Rueter LE. Behavioral profile of P2X7 receptor knockout mice in animal models of depression and anxiety: relevance for neuropsychiatric disorders. Behav Brain Res 198: 83-90, 2009.
4. Bidani AK, Griffin KA. Pathophysiology of hypertensive renal damage: implications for therapy. Hypertension 44: 595-601, 2004.
5. Boesen EI, Williams DL, Pollock JS, Pollock DM. Immunosuppression with mycophenolate mofetil attenuates the development of hypertension and albuminuria in deoxycorticosterone acetate-salt hypertensive rats. Clin Exp Pharmacol Physiol 37: 1016-1022, 2010.
6. Chen CS, Hiura Y, Shen CS, Iwai N. Assessment of mitochondrial DNA polymorphisms in salt-sensitive hypertension in Dahl salt-sensitive rats. Hypertens Res 31: 107-115, 2008.
7. Ferrari D, Pizzirani C, Adinolfi E, Lemoli RM, Curti A, Idzko M, Panther E, Di Virgilio F. The P2X7 receptor: a key player in IL-1 processing and release. J Immunol 176: 3877-3883, 2006.
8. Fischer KG, Saueressig U, Jacobshagen C, Wichelmann A, Pavenstadt H. Extracellular nucleotides regulate cellular functions of podocytes in culture. Am J Physiol Renal Physiol 281: F1075-F1081, 2001.
9. Furlan-Freguia C, Marchese P, Gruber A, Ruggeri ZM, Ruf W. P2X7 receptor signaling contributes to tissue factor-dependent thrombosis in mice. J Clin Invest 121: 2932-2944, 2011.
10. Goncalves RG, Gabrich L, Rosario A Jr, Takiya CM, Ferreira ML, Chiarini LB, Persechini PM, Coutinho-Silva R, Leite M Jr. The role of purinergic P2X7 receptors in the inflammation and fibrosis of unilateral ureteral obstruction in mice. Kidney Int 70: 1599-1606, 2006.
11. Harada H, Chan CM, Loesch A, Unwin R, Burnstock G. Induction of proliferation and apoptotic cell death via P2Y and P2X receptors, respectively, in rat glomerular mesangial cells. Kidney Int 57: 949-958, 2000.
12. Iwai N, Yasui N, Naraba H, Tago N, Yamawaki H, Sumiya H. Klk1 as one of the genes contributing to hypertension in Dahl salt-sensitive rat. Hypertension 45: 947-953, 2005.
13. Ji X, Naito Y, Hirokawa G, Weng H, Hiura Y, Takahashi R, Iwai N. P2X7 receptor antagonism attenuates the hypertension and renal injury in Dahl salt-sensitive rats. Hypertens Res 35: 173-179, 2012.
14. Kajimoto K, Hiura Y, Sumiya T, Yasui N, Okuda T, Iwai N. Exclusion of the catechol-o-methyltransferase gene from genes contributing to salt-sensitive hypertension in Dahl salt-sensitive rats. Hypertens Res 30: 459-467, 2007.
15. Labasi JM, Petrushova N, Donovan C, McCurdy S, Lira P, Payette MM, Brissette W, Wicks JR, Audoly L, Gabel CA. Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response. J Immunol 168: 6436-6445, 2002.
16. Lister MF, Sharkey J, Sawatzky DA, Hodgkiss JP, Davidson DJ, Rossi AG, Finlayson K. The role of the purinergic P2X7 receptor in inflammation. J Inflamm 4: 5, 2007.
17. MacKenzie A, Wilson HL, Kiss-Toth E, Dower SK, North RA, Sur-prenant A. Rapid secretion of interleukin-1beta by microvesicle shedding. Immunity 15: 825-835, 2001.
18. Nava M, Quiroz Y, Vaziri N, Rodriguez-Iturbe B. Melatonin reduces renal interstitial inflammation and improves hypertension in spontaneously hypertensive rats. Am J Physiol Renal Physiol 284: F447-F454, 2003.
19. Palomino-Doza J, Rahman TJ, Avery PJ, Mayosi BM, Farrall M, Watkins H, Edwards CR, Keavney B. Ambulatory blood pressure is associated with polymorphic variation in P2X receptor genes. Hypertension 52: 980-985, 2008.
20. Qu Y, Franchi L, Nunez G, Dubyak GR. Nonclassical IL-1beta secretion stimulated by P2X7 receptors is dependent on inflammasome activation and correlated with exosome release in murine macrophages. J Immunol 179: 1913-1925, 2007.
21. Rodriguez-Iturbe B, Quiroz Y, Nava M, Bonet L, Chavez M, Herrera-Acosta J, Johnson RJ, Pons HA. Reduction of renal immune cell infiltration results in blood pressure control in genetically hypertensive rats. Am J Physiol Renal Physiol 282: F191-F201, 2002.
22. Rostand SG, Kirk KA, Rutsky EA, Pate BA. Racial differences in the incidence of treatment for end-stage renal disease. N Engl J Med 306: 1276-1279, 1982.
23. Sanz JM, Chiozzi P, Di Virgilio F. Tenidap enhances P2Z/P2X7 receptor signalling in macrophages. Eur J Pharmacol 355: 235-244, 1998.
24. Schulze-Lohoff E, Hugo C, Rost S, Arnold S, Gruber A, Brune B, Sterzel RB. Extracellular ATP causes apoptosis and necrosis of cultured mesangial cells via P2Z/P2X7 receptors. Am J Physiol Renal Physiol 275: F962-F971, 1998.
25. Schwiebert EM, Kishore BK. Extracellular nucleotide signaling along the renal epithelium. Am J Physiol Renal Physiol 280: F945-F963, 2001.
26. Solle M, Labasi J, Perregaux DG, Stam E, Petrushova N, Koller BH, Griffiths RJ, Gabel CA. Altered cytokine production in mice lacking P2X7 receptors. J Biol Chem 276: 125-132, 2001.
27. Surprenant A, Rassendren F, Kawashima E, North RA, Buell G. The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 272: 735-738, 1996.
28. Taylor SR, Gonzalez-Begne M, Sojka DK, Richardson JC, Sheardown SA, Harrison SM, Pusey CD, Tam FW, Elliott JI. Lymphocytes from P2X7-deficient mice exhibit enhanced P2X7 responses. J Leukoc Biol 85: 978-986, 2009.
29. Taylor SR, Turner CM, Elliott JI, McDaid J, Hewitt R, Smith J, Pickering MC, Whitehouse DL, Cook HT, Burnstock G, Pusey CD, Unwin RJ, Tam FW. P2X7 deficiency attenuates renal injury in experimental glomerulonephritis. J Am Soc Nephrol 20: 1275-1281, 2009.
30. Vonend O, Turner CM, Chan CM, Loesch A, Dell'Anna GC, Srai KS, Burnstock G, Unwin RJ. Glomerular expression of the ATP-sensitive P2X receptor in diabetic and hypertensive rat models. Kidney Int 66: 157-166, 2004.
31. Yasui N, Kajimoto K, Sumiya T, Okuda T, Iwai N. The monocyte chemotactic protein-1 gene may contribute to hypertension in Dahl salt-sensitive rats. Hypertens Res 30: 185-193, 2007.
32. Yip L, Woehrle T, Corriden R, Hirsh M, Chen Y, Inoue Y, Ferrari V, Insel PA, Junger WG. Autocrine regulation of T-cell activation by ATP release and P2X7 receptors. FASEB J 23: 1685-1693, 2009.
33. Yu T, Junger WG, Yuan C, Jin A, Zhao Y, Zheng X, Zeng Y, Liu J. Shockwaves increase T-cell proliferation and IL-2 expression through ATP release, P2X7 receptors, and FAK activation. Am J Physiol Cell Physiol 298: C457-C464, 2010.